tiprankstipranks
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket NewsBiotech Sector: M&A Fuels Renewed Excitement
19d ago
Novartis price target raised to CHF 108 from CHF 104 at UBS
PremiumThe Fly
Novartis price target raised to CHF 108 from CHF 104 at UBS
24d ago
Novartis price target raised to CHF 95 from CHF 90 at JPMorgan
PremiumThe Fly
Novartis price target raised to CHF 95 from CHF 90 at JPMorgan
24d ago
Novartis FY24 net sales, core operating income guidance raised
PremiumThe FlyNovartis FY24 net sales, core operating income guidance raised
26d ago
Novartis reports Q1 core EPS grew 23% in constant currency to $1.80
PremiumThe Fly
Novartis reports Q1 core EPS grew 23% in constant currency to $1.80
26d ago
NVS Earnings: Novartis Beats Q1 Estimates, Raises Outlook
PremiumMarket News
NVS Earnings: Novartis Beats Q1 Estimates, Raises Outlook
26d ago
MorphoSys Management, Supervisory board recommend Novartis takeover
PremiumThe FlyMorphoSys Management, Supervisory board recommend Novartis takeover
1M ago
Arvinas enters exclusive strategic license agreement with Novartis for ARV-766
PremiumThe Fly
Arvinas enters exclusive strategic license agreement with Novartis for ARV-766
1M ago
Evercore expects Vera Therapeutics to trade up on Alpine acquisition news
PremiumThe Fly
Evercore expects Vera Therapeutics to trade up on Alpine acquisition news
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100